For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Documents
Quantitative Analysis of Designer Benzodiazepines in Urine by LC-MS/MS
Benzodiazepines are among the most often prescribed drugs in the US with significant abuse potential. Analogs to the prescription class of benzodiazepines, often obtained on illicit marketplaces, are not U.S. Food and Drug Administration (FDA) approved and are increasingly finding their place among the population over the last two decades.

Quantitative Analysis of Designer Benzodiazepines in Urine by LC-MS/MS

Benzodiazepines are among the most often prescribed drugs in the US with significant abuse potential. Analogs to the prescription class of benzodiazepines, often obtained on illicit marketplaces, are not U.S. Food and Drug Administration (FDA) approved and are increasingly finding their place among the population over the last two decades.
Document Type:
Poster
Separation Modes:
Beta-Glucuronidase Removal, Reversed Phase, Solid Phase Extraction

Can't view? Disable your browser's pop-up blocker.

Quantitative Analysis of Designer Benzodiazepines in Urine by LC-MS/MS

Benzodiazepines are among the most often prescribed drugs in the US with significant abuse potential. Analogs to the prescription class of benzodiazepines, often obtained on illicit marketplaces, are not U.S. Food and Drug Administration (FDA) approved and are increasingly finding their place among the population over the last two decades.

Can't view? Disable your browser's pop-up blocker.